vs
Side-by-side financial comparison of iQSTEL Inc (IQST) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). iQSTEL Inc runs the higher net margin — -3.2% vs -38.1%, a 34.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -14.9%). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs 24.8%).
iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
IQST vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $84.2M | $83.1M |
| Net Profit | $-2.7M | $-31.6M |
| Gross Margin | 3.5% | 64.9% |
| Operating Margin | -2.9% | -4.1% |
| Net Margin | -3.2% | -38.1% |
| Revenue YoY | -14.9% | 20.2% |
| Net Profit YoY | -44.5% | -27.9% |
| EPS (diluted) | $-0.92 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $84.2M | $76.4M | ||
| Q3 25 | $102.9M | $83.3M | ||
| Q2 25 | $72.2M | $79.2M | ||
| Q1 25 | $57.6M | $69.2M | ||
| Q4 24 | $98.9M | $68.2M | ||
| Q3 24 | $54.2M | $58.4M | ||
| Q2 24 | $78.6M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-2.7M | $-29.8M | ||
| Q3 25 | $-2.3M | $-21.4M | ||
| Q2 25 | $-2.3M | $-19.6M | ||
| Q1 25 | $-1.1M | $-24.7M | ||
| Q4 24 | $-1.9M | $-18.9M | ||
| Q3 24 | $-773.0K | $-21.0M | ||
| Q2 24 | $-2.0M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 3.5% | 60.6% | ||
| Q3 25 | 2.7% | 64.8% | ||
| Q2 25 | 2.6% | 65.4% | ||
| Q1 25 | 3.4% | 63.9% | ||
| Q4 24 | 2.7% | 64.0% | ||
| Q3 24 | 3.7% | 63.2% | ||
| Q2 24 | 2.8% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -2.9% | -40.6% | ||
| Q3 25 | -0.5% | -27.8% | ||
| Q2 25 | -0.9% | -28.0% | ||
| Q1 25 | -1.0% | -39.7% | ||
| Q4 24 | -0.3% | -28.9% | ||
| Q3 24 | -0.1% | -38.4% | ||
| Q2 24 | -0.4% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -3.2% | -39.1% | ||
| Q3 25 | -2.3% | -25.7% | ||
| Q2 25 | -3.3% | -24.7% | ||
| Q1 25 | -2.0% | -35.8% | ||
| Q4 24 | -1.9% | -27.6% | ||
| Q3 24 | -1.4% | -35.9% | ||
| Q2 24 | -2.5% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.92 | $-0.54 | ||
| Q3 25 | $-0.68 | $-0.38 | ||
| Q2 25 | $-0.82 | $-0.35 | ||
| Q1 25 | $-0.44 | $-0.45 | ||
| Q4 24 | $-1.19 | $-0.34 | ||
| Q3 24 | $-0.40 | $-0.40 | ||
| Q2 24 | $-0.90 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.2M | $245.6M |
| Total DebtLower is stronger | $4.1M | $51.7M |
| Stockholders' EquityBook value | $16.3M | $347.7M |
| Total Assets | $51.1M | $487.1M |
| Debt / EquityLower = less leverage | 0.25× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $2.2M | $286.5M | ||
| Q3 25 | $2.3M | $294.3M | ||
| Q2 25 | $2.0M | $302.7M | ||
| Q1 25 | $1.1M | $316.2M | ||
| Q4 24 | $2.5M | $333.7M | ||
| Q3 24 | $2.1M | $196.8M | ||
| Q2 24 | $797.2K | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $4.1M | $51.6M | ||
| Q3 25 | $2.7M | $51.6M | ||
| Q2 25 | $4.5M | $51.5M | ||
| Q1 25 | $3.5M | $51.5M | ||
| Q4 24 | $2.5M | $51.5M | ||
| Q3 24 | $3.2M | $51.4M | ||
| Q2 24 | $2.5M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $16.3M | $365.9M | ||
| Q3 25 | $17.9M | $380.3M | ||
| Q2 25 | $14.3M | $385.8M | ||
| Q1 25 | $11.6M | $389.2M | ||
| Q4 24 | $11.9M | $402.2M | ||
| Q3 24 | $8.1M | $241.2M | ||
| Q2 24 | $7.6M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $51.1M | $508.1M | ||
| Q3 25 | $46.9M | $511.5M | ||
| Q2 25 | $51.4M | $513.1M | ||
| Q1 25 | $42.0M | $519.4M | ||
| Q4 24 | $79.0M | $534.0M | ||
| Q3 24 | $32.4M | $374.1M | ||
| Q2 24 | $30.0M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.25× | 0.14× | ||
| Q3 25 | 0.15× | 0.14× | ||
| Q2 25 | 0.31× | 0.13× | ||
| Q1 25 | 0.31× | 0.13× | ||
| Q4 24 | 0.21× | 0.13× | ||
| Q3 24 | 0.40× | 0.21× | ||
| Q2 24 | 0.34× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | — |
| Free Cash FlowOCF − Capex | $-1.2M | — |
| FCF MarginFCF / Revenue | -1.5% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-1.2M | $-10.3M | ||
| Q3 25 | $-953.0K | $-6.6M | ||
| Q2 25 | $257.7K | $-15.0M | ||
| Q1 25 | $-1.9M | $-17.0M | ||
| Q4 24 | $-403.7K | $-32.4M | ||
| Q3 24 | $625.0K | $-18.8M | ||
| Q2 24 | $-2.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.2M | $-12.2M | ||
| Q3 25 | $-969.2K | $-9.5M | ||
| Q2 25 | $211.7K | $-17.8M | ||
| Q1 25 | $-2.0M | $-18.8M | ||
| Q4 24 | $-421.3K | $-33.6M | ||
| Q3 24 | $594.5K | $-19.0M | ||
| Q2 24 | $-2.6M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | -1.5% | -15.9% | ||
| Q3 25 | -0.9% | -11.4% | ||
| Q2 25 | 0.3% | -22.5% | ||
| Q1 25 | -3.4% | -27.2% | ||
| Q4 24 | -0.4% | -49.2% | ||
| Q3 24 | 1.1% | -32.6% | ||
| Q2 24 | -3.4% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 2.4% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.1% | 2.7% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.1% | 0.4% | ||
| Q2 24 | 0.0% | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
